CFTR and cystic fibrosis: While several CFTR variants different from F508del are included in the U.S. Food and Drug Administration (FDA) list of those approved for CF treatment, in most European countries a variable percentage of people with CF do not have access to ETI because they do not carry the F508del allele on the CFTR gene.